{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:19:19Z","timestamp":1760145559429,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.micpath.2020.104221","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T21:37:01Z","timestamp":1588196221000},"page":"104221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform"],"prefix":"10.1016","volume":"146","author":[{"given":"Mohammad","family":"Gholami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NeginHosseini","family":"Rouzbahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SiamakMirab","family":"Samiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Tayeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-5597","authenticated-orcid":false,"given":"Khodayar","family":"Ghorban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza Dolatyar","family":"Dehkharghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Moshiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Sattari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-7966","authenticated-orcid":false,"given":"Maryam","family":"Dadmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Mohraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9534","key":"10.1016\/j.micpath.2020.104221_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment","volume":"368","author":"Simon","year":"2006","journal-title":"Lancet"},{"year":"2018","series-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV","key":"10.1016\/j.micpath.2020.104221_bib3"},{"issue":"12","key":"10.1016\/j.micpath.2020.104221_bib4","article-title":"First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium","volume":"13","author":"Dessilly","year":"2018"},{"issue":"2","key":"10.1016\/j.micpath.2020.104221_bib5","article-title":"Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: a Retrospective longitudinal study from rural coastal Kenya","volume":"14","author":"Hassan","year":"2019"},{"key":"10.1016\/j.micpath.2020.104221_bib6","first-page":"377","article-title":"Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review","volume":"91","author":"McMahon","year":"2013"},{"issue":"7","key":"10.1016\/j.micpath.2020.104221_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12272-011-0701-3","article-title":"Antiretroviral therapy 2010 update: current practices and controversies","volume":"34","author":"Grant","year":"2011","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.micpath.2020.104221_bib8","first-page":"329","article-title":"Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data","volume":"3","author":"Beerenwinkel","year":"2012"},{"issue":"1","key":"10.1016\/j.micpath.2020.104221_bib9","first-page":"406","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis","volume":"43","author":"Palmer","year":"2005"},{"issue":"10","key":"10.1016\/j.micpath.2020.104221_bib10","first-page":"1588","article-title":"Impact of human immunodeficiency virus type 1 minority variants on the virus response to a rilpivirine-based first-line regimen","volume":"66","author":"Raymond","year":"2018"},{"issue":"2","key":"10.1016\/j.micpath.2020.104221_bib11","article-title":"HIV drug resistance mutations (DRMs) detected by deep sequencing in virologic failure subjects on therapy from Hunan Province, China","volume":"11","author":"Chen","year":"2016"},{"issue":"9","key":"10.1016\/j.micpath.2020.104221_bib12","article-title":"Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA","volume":"12","author":"Tumiotto","year":"2017"},{"issue":"1","key":"10.1016\/j.micpath.2020.104221_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jac\/dkt316","article-title":"Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing","volume":"69","author":"Melikian","year":"2014","journal-title":"J. Antimicrobial Chem."},{"issue":"5","key":"10.1016\/j.micpath.2020.104221_bib14","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/AAC.05487-11","article-title":"Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility","volume":"56","author":"Melikian","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.micpath.2020.104221_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2020.104221_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/430709","article-title":"Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection","volume":"41","author":"Campbell","year":"2005","journal-title":"Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"10.1016\/j.micpath.2020.104221_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 antiretroviral resistance: scientific principles and clinical applications","volume":"72","author":"Tang","year":"2012","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.micpath.2020.104221_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.micpath.2020.104221_bib19","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1128\/AAC.48.8.2993-2998.2004","article-title":"Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1","volume":"48","author":"Turner","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.micpath.2020.104221_bib20","article-title":"Immunoinformatics study of gp120 of human immunodeficiency virus type 1 subtype CRF35_AD isolated from Iranian patients","volume":"11","author":"Keyvani","year":"2016"},{"issue":"1","key":"10.1016\/j.micpath.2020.104221_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/aid.2010.0050","article-title":"Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy","volume":"27","author":"Chaplin","year":"2011","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"4","key":"10.1016\/j.micpath.2020.104221_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jac\/dkx511","article-title":"Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen","volume":"73","author":"Charpentier","year":"2018","journal-title":"J. Antimicrobial Chem."},{"issue":"2","key":"10.1016\/j.micpath.2020.104221_bib23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/AAC.01345-09","article-title":"Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector","volume":"54","author":"Reuman","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2020.104221_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(11)70249-3","article-title":"Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study","volume":"12","author":"Molina","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2020.104221_bib25","first-page":"20","article-title":"First report of drug resistance against HIV-1 integrase inhibitors in Iran","volume":"7","author":"Gholami","year":"2019"},{"key":"10.1016\/j.micpath.2020.104221_bib26","first-page":"31","article-title":"E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settings","volume":"107","author":"Sluis-Cremer","year":"2014"},{"key":"10.1016\/j.micpath.2020.104221_bib27","first-page":"1","article-title":"Evaluation of acquired HIV drug resistance among people living with HIV who have taken antiretroviral therapy for 9-15 Months in 14 triangular clinics in Iran, 2015-2016","author":"Mohraz","year":"2019","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.micpath.2020.104221_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12879-018-3339-7","article-title":"Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis","volume":"18","author":"Al-Mozaini","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2020.104221_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000497036","article-title":"Evaluation of acquired HIV drug resistance among people living with HIV who have taken antiretroviral therapy for 9-15 Months in 14 triangular clinics in Iran, 2015-2016","volume":"61","author":"Mohraz","year":"2018","journal-title":"Intervirology"},{"issue":"9","key":"10.1016\/j.micpath.2020.104221_bib31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/QAD.0000000000000267","article-title":"Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure","volume":"28","author":"Mohamed","year":"2014","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.micpath.2020.104221_bib32","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/jmv.24872","article-title":"Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples","volume":"89","author":"Trabaud","year":"2017","journal-title":"J. Med. Virol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020305088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020305088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:30:47Z","timestamp":1760110247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020305088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0882401020305088"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104221","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104221"}}